Combined treatment with epsilon protein kinase C activator and delta protein kinase C inhibitor ameliorates ischemia reperfusion injury and graft coronary artery disease in murine cardiac allografts - Tanaka, M.; Terry, R.D.; Koyanagi, T.; Inagaki, K.; Kofidis, T.; Mochly-Rosen, D.; Robbins, R.C. (Journal of Heart & Lung Transplantation, 2004)